Close Menu

NEW YORK (360Dx) — SQI Diagnostics announced today that it has partnered with Toronto-based University Health Network to create a rapid, multiplex test and companion point-of-care device for identifying lung transplant candidates.

Under the terms of the deal, Toronto-based SQI will work with scientists at UHN's Toronto Lung Transplant Program to develop the products. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.